Upadacitinib treating bDMARD-IR PsA & Post-marketing surveillance of tofacitinib treating PsA & RA
The IMID Forum11 Loka 2023

Upadacitinib treating bDMARD-IR PsA & Post-marketing surveillance of tofacitinib treating PsA & RA

Peter Nash, Professor at the School of Medicine, Griffith University, and Director of the Rheumatology Research Unit on the Sunshine Coast, Australia, is joined by Laura Coates, an Associate Professor, NIHR clinician scientist and senior clinical research fellow at the Oxford Psoriatic Arthritis Centre as well as Doctor Frank Behrens, Medical director at Goethe-University. The papers covered in this topical discussion highlight two interesting areas of the modern PsA therapeutic landscape. The first of the publications discusses the safety and efficacy of upadacitinib in the treatment of patients with PsA and an inadequate response to bDMARDs through a three-year study. The second, explores an analysis of the real-world safety profile of tofacitinib in the treatment of patients with PsA. If you would like to read more about the topics discussed, head over to cytokinesignalling.com, where you’ll find detailed summary slides of each of the papers.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(416)

Discussing PsA: Advances in Psoriatic Arthritis Management and Treatment Safety

Discussing PsA: Advances in Psoriatic Arthritis Management and Treatment Safety

Join Professor Laura Coates and Professor Philip Mease as they discuss a recent publication examining minimal clinically important improvement thresholds in PsA. This month’s conversation explores rec...

20 Elo 24min

Author Interview: Professor Axel Finckh and Associate Professor Bente Glintborg, August 2026

Author Interview: Professor Axel Finckh and Associate Professor Bente Glintborg, August 2026

Join Professor Peter Nash from the Griffith University in Brisbane; Professor Axel Finckh, from the Division of Rheumatology, Geneva University Hospitals, Geneva, Switzerland; and Bente Glintborg, an ...

13 Elo 26min

Discussing RA: Advanced therapy outcomes in RA

Discussing RA: Advanced therapy outcomes in RA

Join Professor Iain McInnes and Doctor Philip Mease for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, they examine key findings from studies b...

30 Heinä 27min

Author Interview: Professor Laura Coates, July 2026

Author Interview: Professor Laura Coates, July 2026

Join Professor Peter Nash from the Griffith University in Brisbane, and Laura Coates, Professor at the University of Oxford’s Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Scie...

22 Heinä 26min

Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA

Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA

Join Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the long-term safety and efficacy of bimekizumab and ix...

16 Heinä 23min

Author Interview: Dr Murat Torgutalp, June 2026

Author Interview: Dr Murat Torgutalp, June 2026

Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Murat Torgutalp, from the Charité – Universitätsmedizin in Berlin, as they discuss his recent paper ‘Frequency and characteri...

9 Heinä 29min

Discussing RA: Infectious complications of RA treatments

Discussing RA: Infectious complications of RA treatments

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review two recent studies by Etani et al. and George et ...

25 Kesä 9min

Author Interview: Doctor Chung-Mao Kao, May 2026

Author Interview: Doctor Chung-Mao Kao, May 2026

Join Professor Peter Nash from the Griffith University in Brisbane, and Doctor Chung-Mao Kao from Taichung Veterans General Hospital, as they discuss the recent publication ‘Malignancy risk in patient...

23 Kesä 13min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
adhd-podi
rss-liian-kuuma-peruna
psykologia
rss-vapaudu-voimaasi
rss-niinku-asia-on
kesken
koulu-podcast-2
rss-narsisti
ihminen-tavattavissa-tommy-hellsten-instituutti
rss-hereilla
rahapuhetta
rss-luonnollinen-synnytys-podcast
rss-rahamania
rss-uskonto-on-tylsaa
leikitaanko-laakaria
rss-koira-haudattuna
rss-arkea-ja-aurinkoa-podcast-espanjasta